HCA Healthcare, Inc. HCA
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $75.6B | +7% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Net income | $6.8B | +18% | FY ending Dec 31, 2025 |
| Earnings per share | $28.33 | +29% | FY ending Dec 31, 2025 |
| Cash from operations | $12.6B | +20% | FY ending Dec 31, 2025 |
| Capital spending | $4.9B | +1% | FY ending Dec 31, 2025 |
| Share buybacks | $10.1B | +67% | FY ending Dec 31, 2025 |
| Dividends paid | $679.0M | -2% | FY ending Dec 31, 2025 |
| Cash | $1.0B | -46% | FY ending Dec 31, 2025 |
| Long-term debt | $41.6B | +9% | FY ending Dec 31, 2025 |
| Shareholders' equity | $-6.0B | -141% | FY ending Dec 31, 2025 |
| Shares outstanding | 225M | -10% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 6 sales ($31.1M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Sold | 1,694 | $533.37 | $904K | Feb 18, 2026 |
| Jennifer BerresSVP & Chief Human Res. Officer | Sold2 fills | 8,020 | $514.58 avg | $4.1M | Feb 11, 2026 |
| Christopher F. WyattSVP & Controller | Sold | 4,000 | $505.00 | $2.0M | Feb 11, 2026 |
| Samuel N HazenCEO, Director | Sold7 fills | 42,877 | $501.04 avg | $21.5M | Feb 3, 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Sold | 1,500 | $498.09 | $747K | Feb 3, 2026 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Sold | 3,892 | $473.79 | $1.8M | Nov 5, 2025 |
Other insider moves (57): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Other | 7,769 | $429.00 | $3.3M | Aug 26, 2026 |
| Mike A MarksEVP and CFO | Gift | 3,336 | – | – | May 7, 2026 |
| Mike A MarksEVP and CFO | Gift | 3,336 | – | – | May 7, 2026 |
| William R FristDirector, 10% owner | Award | 809 | – | – | Apr 28, 2026 |
| Thomas F Iii FristDirector, 10% owner | Award | 1,041 | – | – | Apr 28, 2026 |
| Andrea B SmithDirector | Award | 509 | – | – | Apr 28, 2026 |
| Wayne Joseph RileyDirector | Award | 509 | – | – | Apr 28, 2026 |
| Michael W MichelsonDirector | Award | 925 | – | – | Apr 28, 2026 |
| Hugh F JohnstonDirector | Award | 809 | – | – | Apr 28, 2026 |
| Nancy Ann DeparleDirector | Award | 509 | – | – | Apr 28, 2026 |
| John ChidseyDirector | Award | 809 | – | – | Apr 28, 2026 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Tax withholding | 3,306 | $540.29 | $1.8M | Feb 13, 2026 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Option exercise | 5,000 | $236.61 | $1.2M | Feb 13, 2026 |
| Samuel N HazenCEO, Director | Tax withholding | 21,323 | $502.05 | $10.7M | Feb 10, 2026 |
| Jon M FosterEVP and COO | Tax withholding | 5,888 | $502.05 | $3.0M | Feb 10, 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Tax withholding | 3,501 | $502.05 | $1.8M | Feb 10, 2026 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Tax withholding | 3,006 | $502.05 | $1.5M | Feb 10, 2026 |
| Jennifer BerresSVP & Chief Human Res. Officer | Tax withholding | 2,515 | $502.05 | $1.3M | Feb 10, 2026 |
| Mike A MarksEVP and CFO | Tax withholding | 1,690 | $502.05 | $848K | Feb 10, 2026 |
| Christopher F. WyattSVP & Controller | Tax withholding | 1,034 | $502.05 | $519K | Feb 10, 2026 |
| Erica RossittoSVP & Chief Nurse Executive | Tax withholding | 418 | $502.05 | $210K | Feb 10, 2026 |
| Christopher F. WyattSVP & Controller | Award | 3,350 | – | – | Feb 10, 2026 |
| Erica RossittoSVP & Chief Nurse Executive | Award | 1,676 | – | – | Feb 10, 2026 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Award | 8,372 | – | – | Feb 10, 2026 |
| Mike A MarksEVP and CFO | Award | 5,026 | – | – | Feb 10, 2026 |
| Samuel N HazenCEO, Director | Award | 54,934 | – | – | Feb 10, 2026 |
| Jon M FosterEVP and COO | Award | 15,696 | – | – | Feb 10, 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Award | 9,628 | – | – | Feb 10, 2026 |
| Jennifer BerresSVP & Chief Human Res. Officer | Award | 7,116 | – | – | Feb 10, 2026 |
| Thomas F Jr Frist10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| Thomas F Jr Frist10% owner | Other | 36,557,141 | – | – | Feb 6, 2026 |
| William R FristDirector, 10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| William R FristDirector, 10% owner | Other | 36,557,141 | – | – | Feb 6, 2026 |
| Thomas F Iii FristDirector, 10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| Thomas F Iii FristDirector, 10% owner | Other | 36,557,141 | – | – | Feb 6, 2026 |
| Patricia F Elcan10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| Patricia F Elcan10% owner | Other | 36,557,141 | – | – | Feb 6, 2026 |
| Holding Ii Hercules10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| Holding Ii Frisco10% owner | Other | 36,629,188 | – | – | Feb 6, 2026 |
| Holding Ii Frisco10% owner | Other | 36,557,141 | – | – | Feb 6, 2026 |
| Jon M FosterEVP and COO | Tax withholding | 16,076 | $513.76 | $8.3M | Feb 5, 2026 |
| Jon M FosterEVP and COO | Option exercise | 29,330 | $139.06 | $4.1M | Feb 5, 2026 |
| Christopher F. WyattSVP & Controller | Tax withholding | 5,674 | $513.76 | $2.9M | Feb 5, 2026 |
| Christopher F. WyattSVP & Controller | Option exercise | 10,670 | $139.06 | $1.5M | Feb 5, 2026 |
| Samuel N HazenCEO, Director | Other | 1,045 | $498.35 | $521K | Feb 4, 2026 |
| Samuel N HazenCEO, Director | Other | 1,045 | $498.35 | $521K | Feb 4, 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Gift | 4,050 | – | – | Feb 3, 2026 |
| Samuel N HazenCEO, Director | Tax withholding | 41,483 | $488.27 | $20.3M | Jan 30, 2026 |
| Samuel N HazenCEO, Director | Option exercise | 84,360 | $81.96 | $6.9M | Jan 30, 2026 |
| Samuel N HazenCEO, Director | Gift | 14,830 | – | – | Nov 14, 2025 |
| Mike A MarksEVP and CFO | Gift | 165 | – | – | Nov 5, 2025 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Tax withholding | 9,278 | $461.56 | $4.3M | Nov 3, 2025 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Option exercise | 13,170 | $236.61 | $3.1M | Nov 3, 2025 |
| Mike A MarksEVP and CFO | Gift | 165 | – | – | Nov 3, 2025 |
| Mike A MarksEVP and CFO | Gift | 165 | – | – | Nov 3, 2025 |
| Samuel N HazenCEO, Director | Tax withholding | 28,173 | $459.68 | $13.0M | Oct 31, 2025 |
| Samuel N HazenCEO, Director | Option exercise | 58,050 | $69.58 | $4.0M | Oct 31, 2025 |
Trades by members of Congress
5 members reported 6 buys and 4 sales since Oct 29, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Jared Moskowitz D | Bought | $1,001–$15K | Jun 17, 2026 | Jul 26, 2026 | Child |
| Jared Moskowitz D | Bought | $1,001–$15K | Jun 17, 2026 | Jul 26, 2026 | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Sep 11, 2025 | Oct 22, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Aug 19, 2025 | Sep 12, 2025 | Spouse |
| Val T. Hoyle D | Sold | $1,001–$15K | Dec 27, 2024 | Sep 12, 2025259 days later | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Jared Moskowitz D | Bought | $1,001–$15K | May 15, 2025 | Jun 27, 2025 | Self |
| Jared Moskowitz D | Bought | $1,001–$15K | May 15, 2025 | Jun 27, 2025 | Child |
| Julie Johnson D | Sold | $1,001–$15K | Apr 7, 2025 | May 14, 2025 | Joint |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Feb 25, 2025 | Mar 27, 2025 | Self |
Latest SEC filings
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Oct 27, 2026
- News filing: Took on new debt, Other news 8-K · Jul 29, 2026
- Quarterly report 10-Q · Jul 28, 2026
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Jul 24, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jul 14, 2026
- News filing: Executive or board change 8-K · Jun 18, 2026
- News filing: Signed a major agreement, Took on new debt, Other news 8-K · Apr 30, 2026
- Quarterly report 10-Q · Apr 29, 2026
- News filing: Shareholder vote results 8-K · Apr 28, 2026
- News filing: Other news 8-K · Apr 27, 2026
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Apr 24, 2026
- Shareholder meeting proxy DEF 14A · Mar 13, 2026
- News filing: Executive or board change 8-K · Feb 25, 2026
- Insider plans to sell 144 · Feb 18, 2026
- Insider plans to sell 144 · Feb 11, 2026
- Annual report 10-K · Feb 10, 2026
- Insider plans to sell 144 · Feb 3, 2026
- Insider plans to sell 144 · Feb 3, 2026
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Jan 27, 2026
- Insider plans to sell 144 · Nov 5, 2025
- News filing: Signed a major agreement, Took on new debt, Other news 8-K · Oct 31, 2025
- Quarterly report 10-Q · Oct 30, 2025
- News filing: Other news 8-K · Oct 27, 2025
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Oct 24, 2025
- Insider plans to sell 144 · Sep 8, 2025
About HCA Healthcare, Inc.
Business description
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- Sector
- Industrial Applications and Services
- Headquarters
- Nashville, TN
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- SEC company number (CIK)
- 860730
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.